Kochi Medical School
Nankoku, Kochi, 783-8505, Japan
NCT Number: NCT00659698
This study evaluated that strict control of perioperative blood glucose following hepatic resection by using an artificial pancreas would improve postoperative surgical site infection.
Looking for future studies?
Notify MeAll sexes
Interventional
Phase 4
Nankoku, Kochi, 783-8505, Japan
This study recruited 70 patients undergoing elective hepatic resection for liver diseases. Perioperative blood glucose concentration was continuously monitored using an artificial pancreas system. We prospectively divided patients into two groups: one for whom glucose levels were controlled using a manual injection of insulin according to the commonly used sliding scale and another that received programmed infusions of insulin determined by the control algorithm of the artificial pancreas.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
artificial pancreas
Other names: an artificial pancreas system (Nikkiso Inc, Tokyo, Japan)
Time frame: 30th postoperative day
Time frame: during the hospitalization
Kochi University
Other
Prevention for Surgical Site Infection After Hepatic Resection
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00488917
Critical Illness, Digestive System Diseases
Brussels, Belgium
View Trial DetailsNCT03221127
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT03235414
Digestive System Diseases, Liver Diseases
Cincinnati, Ohio, United States
View Trial DetailsNCT05272319
Digestive System Diseases, Liver Diseases
Los Angeles, California, United States
View Trial Details